KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Debt Ratio: 2011-2020

Historic Debt Ratio for Nektar Therapeutics (NKTR) over the last 8 years, with Mar 2020 value amounting to 0.27.

  • Nektar Therapeutics' Debt Ratio rose 136.08% to 0.27 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.27, marking a year-over-year increase of 136.08%. This contributed to the annual value of 0.25 for FY2019, which is 121.44% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Debt Ratio of 0.27 as of Q1 2020, which was up 6.00% from 0.25 recorded in Q4 2019.
  • In the past 5 years, Nektar Therapeutics' Debt Ratio registered a high of 0.57 during Q3 2016, and its lowest value of 0.11 during Q2 2018.
  • Its 3-year average for Debt Ratio is 0.19, with a median of 0.12 in 2019.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 79.28% in 2018, then skyrocketed by 136.08% in 2020.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Debt Ratio stood at 0.43 in 2016, then rose by 12.59% to 0.48 in 2017, then crashed by 76.17% to 0.11 in 2018, then surged by 121.44% to 0.25 in 2019, then spiked by 136.08% to 0.27 in 2020.
  • Its Debt Ratio was 0.27 in Q1 2020, compared to 0.25 in Q4 2019 and 0.12 in Q3 2019.